Recent Patents on Anti-Cancer Drug Discovery

Papers
(The H4-Index of Recent Patents on Anti-Cancer Drug Discovery is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Acknowledgement to Contributors49
Acknowledgement to Reviewers43
L-Selenomethylselenocysteine Exerts Inhibitory Effects on the Progressionof Esophageal Cancer by Targeting the PI3K/AKT Signaling Pathway29
Current Prospects for Adrenocortical Carcinoma Pharmacotherapy25
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies22
Research Progress on the Anticancer Activity of Plant Polysaccharides19
Comprehensive Genomic Analysis of Puerarin in Inhibiting Bladder Urothelial Carcinoma Cell Proliferation and Migration19
ZNF146-Mediated HMGB1-NF-κB Signaling Activation as a Therapeutic Target and Prognostic Biomarker in Osteosarcoma18
Patent Selections17
Bioinformatic Analysis and Experimental Validation of HMGA2-AS1 as a Prognostic Biomarker Associated with Immune Infiltration in Gastric Cancer16
Nanomaterials for Diagnosis and Treatment of Lung Cancer: A Review of Recent Patents16
Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta-Analysis and Systematic Review16
Protective Assessment of Novel (BNC Formulation) against Brain Tumor16
Radiotherapy Enhancing and Radioprotective Properties of Berberine: A Systematic Review15
The Present State and Potential Applications of Artificial Intelligence in Cancer Diagnosis and Treatment15
The Prognostic Role of Interferon Gamma-inducible Protein 30 in ClearCell Renal Cell Carcinoma with Immune Infiltrates15
The Application of Nanotechnology in Immunotherapy based Combinations for Cancer Treatment15
0.64678883552551